Pharmacokinetics of eribulin mesylate in patients with solid tumors receiving repeated oral rifampicin.

Translated title of the contribution: Pharmacokinetics of eribulin mesylate in patients with solid tumors receiving repeated oral rifampicin.

L.A. Devriese, P.O. Witteveen, J. Wanders, K. Law, G. Edwards, L. Reyderman, W Copalu, F. Peng, S. Marchetti, J.H. Beijnen, AD Huitema, E.E. Voest, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Pharmacokinetics of eribulin mesylate in patients with solid tumors receiving repeated oral rifampicin.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science